The European Rare Diseases Research Alliance (ERDERA) is excited to announce the upcoming launch of its Joint Transnational Call (JTC) for Proposals 2025. Set to officially open on December 10, 2024, this call will invite research teams from across Europe and beyond to submit collaborative projects focused on “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”.
Application Timeline
The JTC 2025 will follow a two-stage submission process:
- December 10, 2024: Call opens
- February 13, 2025: Pre-proposal submission deadline
- July 9, 2025: Full proposal submission deadline. Funding decisions are expected by December 2025
SAS’ participation in this call was approved by resolution no. 623 of the SAS Presidium on 23 May 2023. The Presidium allocated an indicative budget of up to 40,000€ per year (of which 15,000 € per year is an in-kind contribution of the SAS applicant’s organization) for 1 project with a maximum duration of 3 years.
More information at:
ERDERA Pre-Announces 2025 Joint Transnational Call for Proposals on Rare Disease Therapies – ERDERA
Microsoft Word – EJPRD JTC 2019 – Preliminary announcement.docx (erdera.org)
CONTACT PERSON
Ing. Silvia Kecerová, PhD.
T:+ 421 2 57510 118